GSK Investigational Site

Wonju-si Kangwon-do 220-701

0 studies enrolling now · 1 studies all time

What they study most

Measles-Mumps-Rubella

Studies at this site

• Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age — Completed